These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 15383626)

  • 21. Endogenous regulator of G-protein signaling proteins regulate the kinetics of Galphaq/11-mediated modulation of ion channels in central nervous system neurons.
    Clark MA; Lambert NA
    Mol Pharmacol; 2006 Apr; 69(4):1280-7. PubMed ID: 16368893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of subfamily B/R4 RGS protein function by 14-3-3 proteins.
    Abramow-Newerly M; Ming H; Chidiac P
    Cell Signal; 2006 Dec; 18(12):2209-22. PubMed ID: 16839744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells.
    Li Y; Hashim S; Anand-Srivastava MB
    Cardiovasc Res; 2005 Jun; 66(3):503-11. PubMed ID: 15914115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RGS3 is a GTPase-activating protein for g(ialpha) and g(qalpha) and a potent inhibitor of signaling by GTPase-deficient forms of g(qalpha) and g(11alpha).
    Scheschonka A; Dessauer CW; Sinnarajah S; Chidiac P; Shi CS; Kehrl JH
    Mol Pharmacol; 2000 Oct; 58(4):719-28. PubMed ID: 10999941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxytocin stimulation of RGS2 mRNA expression in cultured human myometrial cells.
    Park ES; Echetebu CO; Soloff S; Soloff MS
    Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E580-4. PubMed ID: 11832360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of spinophilin on the function of RGS8 regulating signals from M2 and M3-mAChRs.
    Kurogi M; Nagatomo K; Kubo Y; Saitoh O
    Neuroreport; 2009 Aug; 20(13):1134-9. PubMed ID: 19609226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered expression of G(q/11alpha) protein shapes mGlu1 and mGlu5 receptor-mediated single cell inositol 1,4,5-trisphosphate and Ca(2+) signaling.
    Atkinson PJ; Young KW; Ennion SJ; Kew JN; Nahorski SR; Challiss RA
    Mol Pharmacol; 2006 Jan; 69(1):174-84. PubMed ID: 16234485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signaling and ligand binding by recombinant neuromedin U receptors: evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interaction.
    Brighton PJ; Szekeres PG; Wise A; Willars GB
    Mol Pharmacol; 2004 Dec; 66(6):1544-56. PubMed ID: 15331768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assays for G-protein-coupled receptor signaling using RGS-insensitive Galpha subunits.
    Clark MJ; Traynor JR
    Methods Enzymol; 2004; 389():155-69. PubMed ID: 15313565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of RGS proteins on G alpha(q) and G alpha(11) activity.
    Ladds G; Goddard A; Hill C; Thornton S; Davey J
    Cell Signal; 2007 Jan; 19(1):103-13. PubMed ID: 16843638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. m3 Muscarinic receptor-induced and Gi-mediated heterologous potentiation of phospholipase C stimulation: role of phosphoinositide synthesis.
    Schmidt M; Nehls C; Rümenapp U; Jakobs KH
    Mol Pharmacol; 1996 Oct; 50(4):1038-46. PubMed ID: 8863852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galphaq-coupled receptor signaling enhances adenylate cyclase type 6 activation.
    Beazely MA; Watts VJ
    Biochem Pharmacol; 2005 Jul; 70(1):113-20. PubMed ID: 15885660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S1P receptor signalling and RGS proteins; expression and function in vascular smooth muscle cells and transfected CHO cells.
    Hendriks-Balk MC; van Loenen PB; Hajji N; Michel MC; Peters SL; Alewijnse AE
    Eur J Pharmacol; 2008 Dec; 600(1-3):1-9. PubMed ID: 18854184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent and selective inhibition of angiotensin AT1 receptor signaling by RGS2: roles of its N-terminal domain.
    Matsuzaki N; Nishiyama M; Song D; Moroi K; Kimura S
    Cell Signal; 2011 Jun; 23(6):1041-9. PubMed ID: 21291998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal Kir3.1/Kir3.2a channels coupled to serotonin 1A and muscarinic m2 receptors are differentially modulated by the "short" RGS3 isoform.
    Jaén C; Doupnik CA
    Neuropharmacology; 2005 Sep; 49(4):465-76. PubMed ID: 15935408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Palmitoylation and its effect on the GTPase-activating activity and conformation of RGS2.
    Ni J; Qu L; Yang H; Wang M; Huang Y
    Int J Biochem Cell Biol; 2006; 38(12):2209-18. PubMed ID: 16945566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in 5-HT2A receptor signaling in male and female transgenic rats over-expressing either Gq or RGS-insensitive Gq protein.
    Shi J; Damjanoska KJ; Zemaitaitis B; Garcia F; Carrasco G; Sullivan NR; She Y; Young KH; Battaglia G; Van De kar LD; Howland DS; Muma NA
    Neuropharmacology; 2006 Sep; 51(3):524-35. PubMed ID: 16769091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between inositol 1,4,5-trisphosphate receptor isoforms and subcellular Ca2+ signaling patterns in nonpigmented ciliary epithelia.
    Hirata K; Nathanson MH; Burgstahler AD; Okazaki K; Mattei E; Sears ML
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2046-53. PubMed ID: 10440260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells.
    Cao X; Qin J; Xie Y; Khan O; Dowd F; Scofield M; Lin MF; Tu Y
    Oncogene; 2006 Jun; 25(26):3719-34. PubMed ID: 16449965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RGS2 interacts with Gs and adenylyl cyclase in living cells.
    Roy AA; Baragli A; Bernstein LS; Hepler JR; Hébert TE; Chidiac P
    Cell Signal; 2006 Mar; 18(3):336-48. PubMed ID: 16095880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.